Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
499 Leser
Artikel bewerten:
(2)

Wolters Kluwer recognized as a 2023 Customers' Choice for Financial Planning Software in Gartner® Peer Insights

Finanznachrichten News

Ninety-seven percent of verified end-users of CCH Tagetik are Willing to Recommend the comprehensive corporate performance management (CPM) platform

NEW YORK, June 1, 2023 /PRNewswire/ -- Wolters Kluwer, a global leader in professional information, software solutions and services, today announced that it has been recognized as a Customers' Choice in the 2023 Gartner Peer Insights Voice of the Customer for Financial Planning Software report; and 97% of verified end-users of CCH Tagetik are Willing to Recommend the comprehensive corporate performance management (CPM) platform, based on 47 reviews as of March 31, 2023.

Wolters Kluwer logo

The 2023 Gartner Peer Insights Voice of the Customer for Financial Planning Software recognizes software vendors based on reviews from verified end-users. This aggregated peer perspective, along with individual detailed reviews, complements Gartner expert research and can play a decisive role in organizations' buying process, as it incorporates peer experiences of implementing and operating a solution. Vendors placed in the upper-right quadrant of the "Voice of the Customer" quadrants are recognized with the Gartner Peer Insights Customers' Choice distinction, denoted with a Customers' Choice badge. The recognized vendors meet or exceed both the market-average Overall Experience and the market-average User Interest and Adoption.

This latest peer-recognition follows Wolters Kluwer's previous positioning as a Leader, based on its Ability to Execute and Completeness of Vision, in the 2022 Gartner® Magic QuadrantTM for Financial Planning Software, which evaluated CCH Tagetik Budgeting, Planning, and Forecasting software.

Read what verified end-user professionals have to say about CCH Tagetik on Gartner Peer Insights. Key excerpts include:

  • "Great software. High flexibility."
  • "Finally a real user-owned planning tool for finance pros!!"
  • "Great software, outstanding support team."
  • "Automation, standardization, efficiency and financial intelligence! Excellent CPMtool."

Ralf Gärtner, Senior Vice President and General Manager of Corporate Performance Solutions, Wolters Kluwer, said:
"We believe being peer-recognized as a Customers' Choice, and receiving a 97% Willingness to Recommend rating, are testaments to the confidence CCH Tagetik customers have in our comprehensive product capabilities. We also see this recognition as a reflection of our relentless commitment to delivering a superior customer experience from sales to deployment to ongoing support."

Gartner Peer Insights Disclaimer
Gartner, Voice of the Customer for Financial Planning Software, Peer Contributors, 29 May 2023. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, MAGIC QUADRANT and PEER INSIGHTS are registered trademarks of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved. Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software, and services for professionals in healthcare, tax and accounting, financial and corporate compliance, legal and regulatory, and corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2022 annual revenues of €5.5 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 20,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

For more information, visit www.wolterskluwer.com, follow us on LinkedIn, Twitter, Facebook, and YouTube.

Media Contact:

Beatriz Santin
CCH® Tagetik
+1 339 229 2447 office
+39 058396811 office
beatriz.santin@wolterskluwer.com

Logo: https://mma.prnewswire.com/media/1441883/Wolters_Kluwer_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/wolters-kluwer-recognized-as-a-2023-customers-choice-for-financial-planning-software-in-gartner-peer-insights-301839963.html

© 2023 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.